OS Therapies’ (OSTX) Buy Rating Reaffirmed at D. Boral Capital
D. Boral Capital reissued their buy rating on shares of OS Therapies (NYSE:OSTX – Free Report) in a report published on Tuesday,Benzinga reports. D. Boral Capital currently has a $20.00 price objective on the stock. Separately, Lake Street Capital began coverage on shares of OS Therapies in a research report on Wednesday, April 2nd. They […]
D. Boral Capital reissued their buy rating on shares of OS Therapies (NYSE:OSTX – Free Report) in a report published on Tuesday,Benzinga reports. D. Boral Capital currently has a $20.00 price objective on the stock. Separately, Lake Street Capital began coverage on shares of OS Therapies in a research report on Wednesday, April 2nd. They […]
